New hope for endometriosis patients: simpler Egg-Freezing protocol shows promise

NCT ID NCT06106919

Completed Disease control Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looked at 130 women with endometriosis who froze their eggs. It compared a drug called dienogest against standard hormone treatments to see if it could collect a similar number of mature eggs. The goal is to find a simpler, effective option for fertility preservation in these patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: dienogest
What this could lead to: If dienogest works as well as standard protocols, it could offer a simpler, hormone-blocking option for preserving fertility in women with endometriosis.
What could go wrong: This is a small, retrospective study (130 participants) comparing only the number of eggs retrieved, not long-term pregnancy success. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endometriosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ENDOMETRIOSIS

Contacts and locations

Locations

CHU de Nîmes

Nîmes, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.